Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-27

Clinical Trial Update: Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 trial to confirm safety and efficacy of Tegoprazan for Healed Erosive Esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegoprazan (tegoprazan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Healed Erosive Esophagitis | Phase 3 | Status: COMPLETED